OrbiMed Private Investments VI, LP Plans to Sell Common Stock of Disc Medicine, Inc.

OrbiMed Private Investments VI, LP has filed a Form 144 with the SEC, indicating its intention to sell 482,308 shares of common stock in Disc Medicine, Inc. The shares were acquired on December 29, 2022, through a business combination. The planned sale is expected to occur on or around October 20, 2025, with an aggregate market value of approximately $43,378,781.52. OrbiMed Capital GP VI LLC is the general partner of OrbiMed Private Investments VI, LP, and OrbiMed Advisors LLC is the managing member of OrbiMed Capital GP VI LLC. The filing also confirms that there have been no sales of securities in the past three months.